Rockwell Medical Stock Revenue
| RMTI Stock | USD 1.76 0.01 0.56% |
Rockwell Medical fundamentals help investors to digest information that contributes to Rockwell Medical's financial success or failures. It also enables traders to predict the movement of Rockwell Stock. The fundamental analysis module provides a way to measure Rockwell Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rockwell Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 96.2 M | 101 M |
Rockwell | Revenue |
Rockwell Medical Company Revenue Analysis
Rockwell Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Rockwell Medical Revenue | 83.61 M |
Most of Rockwell Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rockwell Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Rockwell
Projected quarterly revenue analysis of Rockwell Medical provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Rockwell Medical match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Rockwell Medical's stock price.
Rockwell Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Rockwell Medical is extremely important. It helps to project a fair market value of Rockwell Stock properly, considering its historical fundamentals such as Revenue. Since Rockwell Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rockwell Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rockwell Medical's interrelated accounts and indicators.
| -0.03 | 0.02 | -0.23 | 0.54 | -0.03 | ||
| -0.03 | 0.98 | -0.75 | -0.41 | 0.59 | ||
| 0.02 | 0.98 | -0.73 | -0.44 | 0.56 | ||
| -0.23 | -0.75 | -0.73 | -0.12 | -0.2 | ||
| 0.54 | -0.41 | -0.44 | -0.12 | -0.65 | ||
| -0.03 | 0.59 | 0.56 | -0.2 | -0.65 |
Click cells to compare fundamentals
Rockwell Revenue Historical Pattern
Today, most investors in Rockwell Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rockwell Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Rockwell Medical revenue as a starting point in their analysis.
Rockwell Medical Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Rockwell Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Rockwell Medical reported 83.61 M of revenue. This is 98.9% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.11% higher than that of the company.
Rockwell Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rockwell Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rockwell Medical could also be used in its relative valuation, which is a method of valuing Rockwell Medical by comparing valuation metrics of similar companies.Rockwell Medical is currently under evaluation in revenue category among its peers.
Rockwell Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Rockwell Medical from analyzing Rockwell Medical's financial statements. These drivers represent accounts that assess Rockwell Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Rockwell Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 76.4M | 38.5M | 10.0M | 44.1M | 39.7M | 37.7M | |
| Enterprise Value | 51.6M | 54.1M | 4.8M | 48.5M | 43.7M | 41.5M |
Rockwell Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Rockwell Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Rockwell Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Rockwell Medical's value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 97.9 K | Goldman Sachs Group Inc | 2024-12-31 | 82.7 K | Corsair Capital Management Llc | 2024-12-31 | 75 K | Millennium Management Llc | 2024-12-31 | 74.3 K | Perkins Capital Management Inc | 2024-12-31 | 74 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 71.6 K | Northern Trust Corp | 2024-12-31 | 63.4 K | Hightower Advisors, Llc | 2024-12-31 | 57.4 K | Lpl Financial Corp | 2024-12-31 | 54.9 K | Armistice Capital, Llc | 2024-12-31 | 3 M | Vanguard Group Inc | 2024-12-31 | 1.2 M |
Rockwell Fundamentals
| Return On Equity | -0.0488 | ||||
| Return On Asset | 0.0066 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 50.85 M | ||||
| Shares Outstanding | 32.32 M | ||||
| Shares Owned By Insiders | 12.81 % | ||||
| Shares Owned By Institutions | 25.64 % | ||||
| Number Of Shares Shorted | 438.77 K | ||||
| Price To Earning | (14.72) X | ||||
| Price To Book | 1.89 X | ||||
| Price To Sales | 0.56 X | ||||
| Revenue | 83.61 M | ||||
| Gross Profit | 16.72 M | ||||
| EBITDA | (4.69 M) | ||||
| Net Income | (8.44 M) | ||||
| Cash And Equivalents | 27.56 M | ||||
| Cash Per Share | 2.37 X | ||||
| Total Debt | 13.44 M | ||||
| Debt To Equity | 1.38 % | ||||
| Current Ratio | 2.19 X | ||||
| Book Value Per Share | 0.90 X | ||||
| Cash Flow From Operations | (9.41 M) | ||||
| Short Ratio | 1.89 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Price To Earnings To Growth | (0.79) X | ||||
| Target Price | 6.5 | ||||
| Number Of Employees | 237 | ||||
| Beta | 1.56 | ||||
| Market Capitalization | 54.94 M | ||||
| Total Asset | 52.17 M | ||||
| Retained Earnings | (397.2 M) | ||||
| Working Capital | 12.13 M | ||||
| Current Asset | 84.63 M | ||||
| Current Liabilities | 8.09 M | ||||
| Net Asset | 52.17 M |
About Rockwell Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rockwell Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rockwell Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rockwell Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:Check out Rockwell Medical Piotroski F Score and Rockwell Medical Altman Z Score analysis. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share | Quarterly Revenue Growth 0.191 | Return On Assets | Return On Equity |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.